Enhancement of Thl immune response in mice by the ingestion of Suehirotake (Schizophyllum commune Fries) mycelium

被引:0
|
作者
Kawaguchi, M
Shiomi, R
Tabata, K
Kosuge, Y
Mizumachi, K
Kurisaki, J
机构
[1] Taito Bio Ind Res Corp, Nagata Ku, Kobe, Hyogo 6530023, Japan
[2] Sumika Tech Informat Serv Inc, Chuo Ku, Osaka 5410043, Japan
[3] Natl Inst Livestock & Grassland Sci, Dept Anim Prod Res, Tsukuba, Ibaraki 3050901, Japan
[4] Natl Inst Agrobiol Sci, Genet Divers Dept, Tsukuba, Ibaraki 3058602, Japan
来源
JOURNAL OF THE JAPANESE SOCIETY FOR FOOD SCIENCE AND TECHNOLOGY-NIPPON SHOKUHIN KAGAKU KOGAKU KAISHI | 2004年 / 51卷 / 02期
关键词
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The culture product of Suehirotake (Schizophyllum commune Fries) mycelium (SCP) is supposed to stimulate cellular immunity. In fact, Schizophyllan (beta-1,6-branched beta-1,3-glucan) contained in SCP has anti-tumor activity. In the present study, we investigated the effects of SCP feeding on cytokine production in mice in order to clarify the immunological effects of SCP as a dietary component. The levels of interleukin (IL)-12 and interferon (IFN)-gamma produced in the culture supernatant of spleen cells from SCP-fed mice were significantly high compared to those in control group (P<0.05). Furthermore, the level of IFN-gamma was dependent on the dose of SCP. The level of tumor necrosis factor (TNF)-alpha was not changed by SCP-feeding. These results suggest that SCP could be useful food with immunomodulating activities by promoting Th 1 immune response via oral route.
引用
收藏
页码:102 / 105
页数:4
相关论文
共 41 条
  • [41] Enhancement of the Local CD8+ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens
    Vasilyev, Kirill
    Shurygina, Anna-Polina
    Zabolotnykh, Natalia
    Sergeeva, Mariia
    Romanovskaya-Romanko, Ekaterina
    Pulkina, Anastasia
    Buzitskaya, Janna
    Dogonadze, Marine Z.
    Vinogradova, Tatiana, I
    Stukova, Marina A.
    VACCINES, 2021, 9 (11)